Scientific Advisory Board

Robert S. Rosenson, MD, FACC, FACP, FAHA
Dr. Rosenson is Professor of Medicine and Director of Lipoprotein Disorders and Clinical Atherosclerosis Research / Cardiovascular Diseases at the University of Michigan in Ann Arbor. His clinical research has investigated the effects of lipid-lowering therapies, hypoglycemic therapies and antihypertensive agents on inflammation and thrombogenesis as well as the effects of hypolipidemic and antihypertensive agents on blood viscosity and fibrinogen. Previously, he was Professor of Cardiology at Northwestern University Medical School, where he also served as Director of the Preventive Cardiology Center and Director of the Lipoprotein and Hemorheology Research Facility. After receiving his medical degree from Tulane University, Dr. Rosenson completed his internship and residency at Brigham and Women's Hospital, Harvard Medical School, where he also held a Clinical Fellowship in Medicine. Following that, Dr. Rosenson completed his fellowship in cardiology at the University of Chicago. He has published over 70 peer-reviewed scientific papers and nearly 70 book chapters in the field. He also serves as an editor of a number of journals including Atherosclerosis.

Patrick Moriarty, MD, FACP, FACC
Dr. Moriarty is Associate Professor of Internal Medicine, Director of Clinical Pharmacology, Medical Director of Atherosclerosis and LDL-Apheresis Clinic at the University of Kansas Medical Center in Kansas City. He is one of the world's foremost authorities on LDL-apheresis, a procedure that filters the plasma resulting in an acute reduction of LDL cholesterol, markers of inflammation, and blood rheology. His research interests include atherosclerosis, vascular inflammation, and blood rheology. He has completed over 75 clinical research studies as principal investigator or co-investigator. Research grants from the pharmaceutical industry involve hyperlipidemia, hypertension, diabetes, post-menopause, and obesity. He also participates in research related to LDL-apheresis and its potential use for congestive heart failure, acute coronary syndrome, retinal artery occlusion, and peripheral vascular disease. He has published extensively, sits on the editorial board of the Journal of Clinical Apheresis and Future Lipidology, and has established his own clinic at the University of Kansas Medical Center for the treatment and prevention of vascular disease.

Hau C. Kwaan, MD, PhD, FRCP, FACP
Dr. Kwaan is Professor of Medicine at the Division of Hematology and Oncology at Northwestern University, Feinberg School of Medicine, with a joint appointment as Attending Physician at the Northwestern Memorial Hospital in Chicago. His research focuses on thrombosis, fibrinolysis, hematology and vascular biology. From 1990-1995, Dr. Kwaan served on the editorial board of Thrombosis Research. Dr. Kwaan received his MD from the University of Hong Kong, with postgraduate medical training at the University of Edinburgh and the University of London, and a fellowship at Columbia University in New York City. He is a Fellow of the Royal College of Physicians of London and a founding member of the International Society of Thrombosis and Haemostasis. He is the recipient of numerous awards and honors. He is the author of over 300 journal articles and the editor of two medical textbooks: Thrombosis and Clinical Thrombosis.

Herbert J. Meiselman, ScD
Dr. Meiselman is Vice-Chair and Professor of Physiology and Biophysics at the University of Southern California Keck School of Medicine. For over 30 years, his research has focused on the science of blood flow in its various aspects, including but not limited to the effects of various pharmaceutical or biochemical interventions, in-depth analysis of the behavior of the components of blood, instrumentation and techniques for biophysical measurements including blood viscosity, and a wide variety of clinical studies related to blood flow and the biophysics of the blood. He is an author of over 200 peer-review journal articles and the editor of two textbooks: Erythrocyte Mechanics and Blood Flow and White Cell Mechanics: Basic Science and Clinical Aspects. Dr. Meiselman received his doctorate of science from the Massachusetts Institute of Technology in 1965, followed by a post-doctoral research fellowship at the California Institute of Technology.